To include your compound in the COVID-19 Resource Center, submit it here.

Bridion sugammadex regulatory update

FDA's Anesthetic and Analgesic Drug Products Advisory Committee will meet July 18 to discuss a resubmitted NDA from Merck for

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE